Zoetis Inc. (NYSE:ZTS) Shares Sold by My Legacy Advisors LLC

My Legacy Advisors LLC cut its holdings in Zoetis Inc. (NYSE:ZTS) by 3.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 3,544 shares of the company’s stock after selling 133 shares during the quarter. My Legacy Advisors LLC’s holdings in Zoetis were worth $592,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in ZTS. Artemis Investment Management LLP lifted its holdings in shares of Zoetis by 55.0% during the fourth quarter. Artemis Investment Management LLP now owns 273,578 shares of the company’s stock worth $44,574,000 after purchasing an additional 97,036 shares during the period. Steigerwald Gordon & Koch Inc. lifted its position in Zoetis by 2.1% in the fourth quarter. Steigerwald Gordon & Koch Inc. now owns 116,603 shares of the company’s stock valued at $18,998,000 after purchasing an additional 2,418 shares during the period. Romano Brothers AND Company boosted its holdings in Zoetis by 15.3% in the 4th quarter. Romano Brothers AND Company now owns 3,911 shares of the company’s stock valued at $637,000 after purchasing an additional 520 shares in the last quarter. Aaron Wealth Advisors LLC increased its position in Zoetis by 39.1% during the 4th quarter. Aaron Wealth Advisors LLC now owns 3,647 shares of the company’s stock worth $594,000 after purchasing an additional 1,026 shares during the period. Finally, IAM Advisory LLC raised its stake in shares of Zoetis by 2.6% during the 4th quarter. IAM Advisory LLC now owns 10,022 shares of the company’s stock worth $1,633,000 after buying an additional 251 shares in the last quarter. 92.80% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on ZTS. Leerink Partners started coverage on shares of Zoetis in a research note on Monday, December 2nd. They set an “outperform” rating and a $215.00 price target on the stock. UBS Group assumed coverage on Zoetis in a report on Monday, December 9th. They issued a “neutral” rating and a $196.00 price target on the stock. Leerink Partnrs raised Zoetis to a “strong-buy” rating in a report on Monday, December 2nd. JPMorgan Chase & Co. increased their price objective on shares of Zoetis from $225.00 to $230.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. Finally, Stifel Nicolaus cut their target price on shares of Zoetis from $210.00 to $180.00 and set a “buy” rating for the company in a research report on Tuesday, January 7th. One research analyst has rated the stock with a hold rating, nine have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, Zoetis currently has an average rating of “Buy” and a consensus target price of $211.89.

Zoetis Stock Performance

Zoetis stock opened at $166.01 on Friday. The stock has a fifty day moving average price of $170.93 and a 200 day moving average price of $179.95. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $200.53. The firm has a market capitalization of $74.90 billion, a P/E ratio of 31.20, a PEG ratio of 2.51 and a beta of 0.89. The company has a current ratio of 3.69, a quick ratio of 2.27 and a debt-to-equity ratio of 1.26.

Zoetis (NYSE:ZTS) last released its earnings results on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.46 by $0.12. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The business had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.29 billion. During the same period last year, the company earned $1.36 earnings per share. The company’s quarterly revenue was up 11.6% on a year-over-year basis. Equities research analysts anticipate that Zoetis Inc. will post 5.91 earnings per share for the current year.

Zoetis Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 4th. Shareholders of record on Tuesday, January 21st will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.20%. The ex-dividend date of this dividend is Tuesday, January 21st. This is an increase from Zoetis’s previous quarterly dividend of $0.43. Zoetis’s payout ratio is 32.52%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.